🔗 Share this article

Given that America continues making unprecedented revisions to its vaccine guidelines, one figure has surfaced somewhat surprisingly: Tracy Beth Høeg, a US-based sports medicine doctor and public health researcher who initially gained attention by casting doubt on coronavirus shots in the pandemic and has zeroed in on possible fatalities following COVID-19 vaccination in her short tenure at the Food and Drug Administration.

Proposed Changes to Pediatric Immunization Program

Agency leaders had intended to unveil radical changes to the childhood immunization program in December, bringing the US with Denmark’s immunization schedule, according to reports – a major change that would put the US at odds with much of the international standard with no evidence for benefit. The announcement has been delayed until the next year.

Rather than Vinay Prasad, Dr. Høeg is scheduled to present at the event. She was newly appointed interim head of the FDA’s CDER, the fifth individual to lead the center this calendar year.

A New Direction at the Regulatory Body

Høeg's temporary position could signify a strengthened alliance between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad strengthen their influence at the FDA – and it points to a renewed priority upon dismantling long-standing immunizations at the FDA.

Høeg has frequently advocated for ending certain childhood shot schedules in the US so as to align more in line with the Danish model, a society with universal health coverage and a number of inhabitants approximately the population of Wisconsin’s.

So far comments, she has persisted in emphasizing on vaccines – usually the responsibility of Dr. Prasad, chief of the FDA’s CBER – instead of medication approval.

Concerns Over Background

Dr. Høeg has little discernible experience in medication creation, oversight or leadership, which has been customary for former leaders of the biologics center. She has worked at the FDA as a senior adviser to the FDA chief and CBER since spring.

“She doesn’t seem to have any of the qualifications” for overseeing the pharmaceutical oversight division, remarked Jonathan Howard. “She’s never run a scientific study. She is not versed in leading a large organization. She has no expertise in pharmaceutical oversight.”

Former heads of the center would “grasp laws and regulations and the underlying principles of medication creation”, commented Janet Woodcock. “Clearly, she doesn’t have the type of experience that former directors who headed the center have had.”

The drug center has an vast portfolio at the agency, she emphasized.

“Many people just zeroes in on the innovative therapies, but the generic program clears a multitude of off-brand pharmaceuticals. There is also a biosimilars program, OTC medication office and more, and all of those must be managed,” Woodcock explained. “The area you neglect, that’s the thing that I always told people is going to come back to haunt you.”

Additionally, a significant administrative element to the job, which oversees in excess of 5,000 staff members. “It’s a huge management job, if you do it right,” she concluded.

Response and Disputed Programs

Regarding inquiries about Dr. Høeg's qualifications and whether this appointment signifies increased cooperation among regulatory chiefs on vaccines, a spokesperson stated that the “questions rely on incorrect premises”.

“This background matches the duties of her role,” the representative stated, noting the months Høeg spent guiding the agency head on “pharmaceutical safety and oversight research, including predictive safety algorithms and shot safety tracking”.

In her interim role, Dr. Høeg inherits the commissioner’s new fast-track approval initiative, a controversial expedited therapy clearance system that allegedly worried her predecessors. “By what process are these medications being selected for this voucher program? Who takes the choices?” Howard questioned. “There is a lot of confidentiality occurring at the regulatory body right now.”

Broadly speaking, he remarked, “the Food and Drug Administration looks to be trending towards laxer oversight of all drugs, with the exception of immunizations.”

Public Track Record on Immunizations

With immunizations, Dr. Høeg has a more established, if troubling, track record, Howard said. She released a study using non-validated crowd-sourced reports to assess the rate of heart inflammation following COVID-19 immunization. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who was said to have altered data to imply COVID-19 vaccinations are pose a greater threat than they are.

Part of her “wish list” for the current administration featured altering regulations for new vaccines and ending “optional” vaccines, she said post-election on a podcast. At the agency, Dr. Høeg has reportedly proposed excluding teenage boys from receiving Covid vaccines.

“She’s an thorough true believer who begins with her preconceived notions and works backwards to fit the evidence in a highly misleading, fraudulent fashion,” Howard stated.

Taking Control and a “Campaign of Retribution”

Dr. Høeg aligned with fellow contrarians, {like|